نتایج جستجو برای: thalidomide

تعداد نتایج: 3195  

2011
Hideyuki Arai Akira Furusu Tomoya Nishino Yoko Obata Yuka Nakazawa Masayuki Nakazawa Misaki Hirose Katsushige Abe Takehiko Koji Shigeru Kohno

Thalidomide is clinically recognized as a therapeutic agent for multiple myeloma and has been known to exert anti-angiogenic actions. Recent studies have suggested the involvement of angiogenesis in the progression of peritoneal fibrosis. The present study investigated the effects of thalidomide on the development of peritoneal fibrosis induced by injection of chlorhexidine gluconate (CG) into ...

2006
Sang Hoon Han Se Hoon Park Jung Ho Kim Jong Jun Lee So Young Kwon Oh Sang Kwon Sun Suk Kim Ju Hyun Kim Keon Kug Kim Yeon Ho Park Jeong Nam Lee Eunmi Nam Soo-Mee Bang Eun Kyung Cho Dong Bok Shin Jae Hoon Lee

BACKGROUND Thalidomide has been reported to have antitumor activity for treating metastatic hepatocellular carcinoma (HCC). We evaluated the safety and efficacy of using thalidomide for treating selected patients with unresectable or metastatic HCC, and their disease was refractory to systemic chemotherapy. METHODS Eight patients with measurable and metastatic HCC that had progressed with pri...

Journal: :Leprosy review 2015
Nagar Rahul Khare Suneel Sanjay Sengar Singh

Type 2 lepra reactions, and its cutaneous manifestation, Erythema Nodosum Leprosum (ENL) are an immune complex mediated systemic condition, often complicating the disease and/or its treatment in cases of the lepromatous spectrum of leprosy. Prednisolone and thalidomide are the mainstay for the treatment of Type 2 lepra reactions. According to the guidelines set out by the WHO and the National L...

Journal: :Brain research 2010
Li Zhang Yi Qu Jun Tang Dapeng Chen Xuemei Fu Meng Mao Dezhi Mu

Thalidomide, a derivative of glutamic acid, is used for immunomodulatory therapy in various diseases through inhibition of tumor necrotic factor-α (TNF-α) release. However, the effects of thalidomide in central nervous system (CNS) diseases such as stroke or hypoxic-ischemic encephalopathy (HIE) are unknown. In this study, we aimed to test whether thalidomide protects against hypoxic-ischemic n...

Journal: :Scandinavian Journal of History 2022

This article analyses how economic support and social benefits for thalidomide-affected children were negotiated organized by both public private actors in 1960s Sweden. Accounts from various archives are used to analyse two different but coexisting understandings of disability – as a medical problem influenced underpinned not only the rehabilitation The Swedish programme arranged affected chil...

Journal: :Blood 2011
Peter M Fayers Antonio Palumbo Cyrille Hulin Anders Waage Pierre Wijermans Meral Beksaç Sara Bringhen Jean-Yves Mary Peter Gimsing Fabian Termorshuizen Rauf Haznedar Tommaso Caravita Philippe Moreau Ingemar Turesson Pellegrino Musto Lotfi Benboubker Martijn Schaafsma Pieter Sonneveld Thierry Facon

The role of thalidomide for previously untreated elderly patients with multiple myeloma remains unclear. Six randomized controlled trials, launched in or after 2000, compared melphalan and prednisone alone (MP) and with thalidomide (MPT). The effect on overall survival (OS) varied across trials. We carried out a meta-analysis of the 1685 individual patients in these trials. The primary endpoint...

2014
Maria Stella de Mello Ayres Putinatti Joel Carlos Lastória Carlos Roberto Padovani

BACKGROUND Leprosy can have its course interrupted by type 1 and 2 reactional episodes, the last named of erythema nodosum leprosum (ENL). Thalidomide has been the medication of choice for the control of ENL episodes since 1965. OBJECTIVES These episodes can repeat and cause damages to the patient. In order to prevent these episodes, an extra dose of 100 mg/day thalidomide was used during six...

2010
Jeong Il Choi Woong Mo Kim Myung Ha Yoon Hyung Gon Lee

BACKGROUND Tumor necrosis factor-alpha and other proinflammatory cytokines are becoming well recognized as key mediators in the pathogenesis of many types of neuropathic pain. Thalidomide has profound immunomodulatory actions in addition to their originally intended pharmacological actions. There has been debate on the analgesic efficacy of opioids in neuropathic pain. The aim of this study was...

Journal: :Scientific reports 2016
Yasuhiro Kazuki Masaharu Akita Kaoru Kobayashi Mitsuhiko Osaki Daisuke Satoh Ryo Ohta Satoshi Abe Shoko Takehara Kanako Kazuki Hiroshi Yamazaki Tetsuya Kamataki Mitsuo Oshimura

Thalidomide is a teratogen in humans but not in rodents. It causes multiple birth defects including malformations of limbs, ears, and other organs. However, the species-specific mechanism of thalidomide teratogenicity is not completely understood. Reproduction of the human teratogenicity of thalidomide in rodents has previously failed because of the lack of a model reflecting human drug metabol...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1981
G B Gordon S P Spielberg D A Blake V Balasubramanian

It was postulated that thalidomide causes birth defects by being metabolized to a toxic electrophilic intermediate. This hypothesis was tested by using an in vitro assay in which drug toxicity to human lymphocytes was assessed in the presence of a hepatic microsomal drug metabolizing system. Maternal hepatic microsomes from pregnant rabbits mediated the production of a metabolite that was toxic...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید